A Medicare & Biosimilars “WIN”

Greetings from Washington, DC where I, as chairman of the American College of Rheumatology’s Government Affairs Committee, had the honor to organize rheumatologists from around the country holding more than 100 meetings on Capitol Hill on Thursday supporting reforms to step therapy (“fail first”) and prior authorization, increased screening for osteoporosis, solutions to the rheumatology workforce shortage, and […]

The breakdown of the main rheumatology advocacy in 2019

A belated Happy New Year to everyone! Here’s another update about what’s going on in Washington for the rheumatology community, from my perspective as a rheumatologist and volunteer chair of the American College of Rheumatology Government Affairs Committee. Please read, forward freely, and consider doing more advocacy as a New Year’s Resolution — it’s easy, […]

Great News for the Rheumatology Community

Angus Worthing MD Greetings, Advocates! Great news for the rheumatology community came on February 9, 2018 as the Bipartisan Budget Act of 2018 was enacted. It contained several critical health care fixes. First, after hundreds of emails, meetings, letters to the editor, an op-ed and a forceful 109-member coalition letter led by the American College of Rheumatology (ACR) […]

High drug costs on doctors and patients, and other top line issues for 2018

By: Dr. Angus Worthing MD, FACP, FACR Washington is back to work after the holiday recess and they’re busily trying to avoid a government shutdown on January 19. This week will likely see a short-term continuing resolution (“CR”) to keep the government running at current funding levels through mid-February. At some point, it would be great for Congress […]

gout-conditions

The New York Times Dr. Herbert S.B. Baraf Back to Common Conditions > Why Do I Have Gout? If one night you wake with the feeling that a big toe has suddenly become a battlefield, and a peek under the covers reveals not This Little Piggy but an angry red monstrosity from some old horror movie, […]

© 2023 All Rights Reserved.